May 14, 2024
DELIVER presentations at ESC HFA 2024
The DELIVER team was proud to present at ESC Heart Failure Association 2024 in Lisbon, Portugal. The following analyses were presented:
Influence of achieved LVEF on efficacy of dapagliflozin in patients with heart failure with improved ejection fraction: the DELIVER trial by Sara Rodrigues De Oliveira Siqueira
Conventional medical therapies in patients with heart failure across different risk for transthyretin amyloid cardiomyopathy in the DELIVER, PARAGON-HF and TOPCAT Americas trials presented by Riccardo Maria Inciardi
Effects of dapagliflozin on new-onset diabetes in patients with heart failure: a pooled, participant-level analysis of the DAPA-HF and DELIVER trials presented by Mats Lassen *Award Session*